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Background: Insomnia is becoming increasingly recognized as a clinically important symptom in patients 
with chronic low back pain (CLBP). In this retrospective study, we have determined risk factors associated 
with clinical insomnia in CLBP patients in a university hospital in Korea.
Methods: Data from four-hundred and eighty one CLBP patients was analyzed in this study. The Insomnia 
Severity Index (ISI) was used to determine the presence of clinical insomnia (ISI score ≥ 15). Patients’ 
demographics and pain-related factors were evaluated by logistic regression analysis to identify risk factors of 
clinical insomnia in CLBP. 
Results: It was found that 43% of patients reported mild to severe insomnia after the development of back 
pain. In addition, 20% of patients met the criteria for clinically significant insomnia (ISI score ≥ 15). In a 
stepwise multivariate analysis, high pain intensity, the presence of comorbid musculoskeletal pain and 
neuropathic pain components, and high level of depression were strongly associated with clinical insomnia in 
CLBP. Among these factors, the presence of comorbid musculoskeletal pain other than back pain was the 
strongest determinant, with the highest odds ratio of 8.074 (95% CI 4.250 to 15.339) for predicting clinical 
insomnia. 
Conclusions: Insomnia should be addressed as an integral part of pain management in CLBP patients with 
these risk factors, especially in patients suffering from CLBP with comorbid musculoskeletal pain. (Korean 
J Pain 2015; 28: 137-143)
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INTRODUCTION
Chronic low back pain (CLBP) is associated with many 
aspects of a poor quality of life [1]. Insomnia is becoming 
increasingly recognized as a clinically important symptom 
in patients with CLBP [2]. Recent studies have reported 
that self-reported sleep disturbance affects up to 55% of 
people with CLBP [3-5]. 
Most often, insomnia is defined by the presence of an 
individual’s report of difficulty with sleep [6]. Insomnia is 
associated with reduced sleep duration and quality, in-
creased time to fall asleep, poor daytime function, and 
greater sleep dissatisfaction and distress [7]. Because in-
somnia has been shown to have negative effects on pain, 
mood, and physical functioning, it may also negatively af-
fect the clinical outcomes of patients with CLBP [1]. The 
treatment of insomnia or depression may result in positive 
outcomes of CLBP [8]. However, pain clinics do not nor-
mally have the resources or expertise to provide a detailed 
sleep assessment for CLBP patients complaining of insom-
nia. Unfortunately, there have not been any published 
studies detailing the prevalence and severity of insomnia 
and/or factors associated with insomnia in CLBP using a 
large database in Korea. 
The Insomnia Severity Index (ISI) is a brief instrument 
which measures patients’ perceptions of their insomnia 
and the levels of severity [9]. The Korean version of the 
ISI has shown good psychometric properties, including 
good convergent validity, discriminate validity and test-re-
test reliability [10]. Since 2012, we have collected the ISI 
data in pain patients for the purpose of clinical audits. 
The primary aim of this retrospective study is to de-
termine the risk factors associated with clinical insomnia 
based on ISI scores in CLBP patients at a university hospi-
tal in Korea.
MATERIALS AND METHODS
This study was approved by the Institutional Review 
Board of Severance Hospital, and a written informed con-
sent was waived. The sample population in this study was 
defined as CLBP patients who received treatment for their 
pain and completed the ISI between June of 2012 and June 
of 2013 at our outpatient clinic. CLBP was defined as pain, 
muscle tension or stiffness localized below the costal mar-
gin and above the inferior gluteal folds, with or without leg 
pain (sciatica). Chronicity was established by the persis-
tence of pain beyond 12 weeks of symptoms. We excluded 
patients suffering from current infectious diseases, cancer, 
and psychiatric or neurologic disorders, which are known 
to affect sleep. Patients who reported that their insomnia 
predated the onset of back pain by more than 1 month and 
who were diagnosed with obstructive sleep apnea or pe-
ripheral neuropathy were also excluded.
The prevalence and severity of insomnia were assessed 
using the ISI data, which was recorded during an interview 
upon the first visit. The ISI consists of seven items which 
assess the following: the severity of sleep onset and sleep 
maintenance difficulties, satisfaction with one’s current 
sleep pattern, the degree of interference with normal daily 
functioning, the degree of impairment attributable to sleep 
problems, and the degree of distress or concern caused by 
the sleep problems. Each compartment is graded on a 
five-point scale (0 to 4), and the global score ranges from 
0 to 28 with higher scores indicative of more severe 
insomnia. Following the recommended score interpretation 
guidelines [9], a global score of 0-7 indicates “no clinically 
significant insomnia,” 8-14 “sub-threshold insomnia,” 
15-21 “moderate clinical insomnia,” and 22-28 “severe 
clinical insomnia.” For the purpose of this study, clinical 
insomnia was defined as cases with a score higher than 
15 on the ISI scale. Additional patient data that was col-
lected includes age, gender, body mass index (BMI), dura-
tion of pain, pain score measured on a 0 to 10 numeric 
rating scale (NRS), the presence of leg pain, a previous 
spine surgery history, comorbid musculoskeletal pain con-
ditions (musculoskeletal pain other than low back pain), 
symptoms suggesting neuropathic pain (patient-reported 
symptoms including dysesthesia or allodynia, burning or 
coldness, pins and needles sensations, numbness and 
itching, except for the low back region), and levels of anxi-
ety and depression assessed by the 14 items on the 
Hospital Anxiety and Depression Scale (HADS) [11]. These 
14 items, scored on a scale of 0 to 3 in each case, measure 
the degree of anxiety (seven items) and depression (seven 
items). Thus, the two subscales range from 0 to 21, with 
higher scores indicating an increased likelihood of an 
anxiety or depressive disorder being present. The cut-off 
value for the identification of suspected cases is generally 
considered to be 8 out of 21 points [11].
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Table 2. Insomnia Severity Index Score Data 
n = 481
Global score of Insomnia Severity Index 7.5 ± 7.1 (0−28)
Severity of insomnia
  0−7; no insomnia 274 (57.0%)
  8−14; sub-threshold insomnia 111 (23.0%)
  15−21; clinical insomnia (moderate) 71 (14.7%)
  22−28; clinical insomnia (severe) 25 (5.3%)
Values are means ± SD (range) or number of patients (%).
Table 1. Demographics and Clinical Characteristics
n = 481
Age, years 58.2 ± 16.7 (20−90)
Gender, M/F 195/286
Body mass index, kg/m2 23.8 ± 3.3 (14−35)
Pain duration, months 40.8 ± 65.9 (3 months−40 years)
Pain score, 0 to 10 NRS 6.6 ± 1.9 (1−10)
Diagnosesa, n
  Lumbar disc herniation 136 (28%)
  Spinal stenosis 191 (39%)
  Spondylolisthesis 24 (5%)
  Musculoskeletal back pain 61 (12%)
  Othersb 69 (14%)
Values are means ± SD (range) or number of patients (%). NRS:
numeric rating scale. amain diagnoses related to pain confirmed by
image studies such as MRI or CT. bmixed cases.
　1. Statistical analysis
Continuous variables are shown as the mean ± stand-
ard deviation (SD), and categorical variables are shown as 
numbers (percentages). Logistic regression was used to 
compute crude odds ratios (ORs) with 95% confidence in-
tervals (CIs) for variables associated with clinical insomnia 
(≥ 15 of the ISI score). The variables used for analysis in-
cluded demographic data (age, gender, BMI), a history of 
hypertension or diabetes mellitus, and duration of pain (＜ 
1 year or ≥ 1 year), pain score (＜ 7 NRS or ≥ 7 NRS), 
the presence of leg pain, previous spine surgery history, 
comorbid musculoskeletal pain, neuropathic pain compo-
nents, and anxiety and depression (＜ 8 HADS or ≥ 8 
HADS). Variables with a P value of less than 0.05 were 
included in the multivariate logistic regression analysis 
which estimated adjusted ORs with 95% CIs. Statistical 
analysis was performed with the Statistical Package for 
Social Sciences (SPSS, version 18.0; SPSS Inc., Chicago, 
IL, USA). Values of P ＜ 0.05 were considered as statisti-
cally significant.
　RESULTS
A total of 481 patients with CLBP satisfied the study 
inclusion criteria and were included in the analyses. The 
patients’ demographics and CLBP characteristics are shown 
in Table 1. Most of the patients suffered from mechanical 
back pain, including lumbar disc herniation (28%) and spi-
nal stenosis (39%). 
The mean global ISI score was 7.5 with a wide varia-
tion, and 43% of patients reported mild to severe insomnia 
(ISI score ≥ 8) after the development of back pain. Clinical 
insomnia of a moderate to severe severity level as meas-
ured by the ISI was found in 20% of patients (Table 2). 
In the univariate analysis, we found that a high pain 
score with NRS ≥ 7, the presence of comorbid muscu-
loskeletal pain, the presence of neuropathic pain symp-
toms, and high levels of anxiety and depression with HADS 
≥ 8 were significantly associated with clinical insomnia 
(Table 3). The multivariate logistic regression analysis re-
vealed that a high pain score with NRS ≥ 7, the presence 
of comorbid musculoskeletal pain, the presence of neuro-
pathic pain symptoms, and high levels of depression with 
HADS ≥ 8 were significantly associated with clinical in-
somnia in our study population (Table 3). Among the afore-
mentioned findings, the presence of comorbid muscu-
loskeletal pain other than back pain was the strongest de-
terminant, with the highest odds ratio of 8.074 (95% CI 
4.250 to 15.339) for predicting clinical insomnia. 
DISCUSSION
In the present study, our finding confirmed that in-
somnia is not uncommon in CLBP patients. We found that 
high pain intensity, the presence of comorbid muscu-
loskeletal pain and neuropathic pain components, and the 
depression level were strongly associated with clinical in-
somnia in this population. 
The ISI was used in the current study to determine the 
presence or absence of clinical insomnia. Twenty percent 
of patients in this study were suggestive of clinically sig-
nificant insomnia (ISI ≥ 15). This proportion is approx-
imately two times lower than the percentages of 44% to 
53% from two previous studies involving European CLBP 
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Table 3. Factors Associated with Clinical Insomnia (≥ 15 Insomnia Severity Index Score) in Chronic Low Back Pain: Results of the Logistic
Regression Analysis
Factors n (%) Crude OR (95% CI) P value Adjusted OR (95% CI) P value
Gender 0.162 0.571
    Men 195 1.000 1.000
    Women 286 1.395 (0.875−2.226) 1.196 (0.645−2.216)
Age 0.554 0.548
    ＜ 65 years 273 1.000 1.000
    ≥ 65 years 208 1.145 (0.731−1.795) 0.832 (0.458−1.513)
Body mass index 0.883
    ＜ 25 kg/m2 378 1.000
    ≥ 25 kg/m2 103 1.044 (0.590−1.849)
Hypertension 0.434
    No 383 1.000
    Yes 98 1.121 (0.612−1.569)
Diabetes mellitus 0.610
    No 400 1.000
    Yes 81 1.004 (0.799−1.354)
Pain duration 0.521
    ＜ 1 year 263 1.000
    ≥ 1 year 218 1.148 (0.733−1.791)
Pain score ＜ 0.001 0.007
    ＜ 7 NRS 243 1.000 1.000
    ≥ 7 NRS 238 2.569 (1.602−4.122) 2.342 (1.257−4.365)
Leg pain (sciatica) 0.276
    No 284 1.000
    Yes 297 1.299 (0.811−2.081)
Spine surgery history 0.566
    No 438 1.000
    Yes 43 1.244 (0.590−2.622)
Comorbid musculoskeletal pain 
conditions (except low back) 
＜ 0.001 ＜ 0.001
    No 394 1.000 1.000
    Yes 87 14.708 (8.559−25.276) 8.074 (4.250−15.339)
Neuropathic pain components
(except low back)
＜ 0.001 0.001
    No 336 1.000 1.000
    Yes 145 3.424 (2.156−5.437) 2.775 (1.518−5.074)
Anxiety ＜ 0.001 0.336
    ＜ 8 HADS 384 1.000 1.000
    ≥ 8 HADS 97 3.135 (1.912−5.141) 1.444 (0.683−3.056)
Depression ＜ 0.001 0.011
    ＜ 8 HADS 383 1.00 1.00
    ≥ 8 HADS 98 5.577 (3.308−9.404) 2.614 (1.241−5.505)
Significant variables (P ＜ 0.05) in univariate analysis were selected for multivariate analysis. Age and gender were included in the 
multivariate analysis because these are identified demographic risk factors for insomnia in the general population [6]. OR: odds ratio, CI:
confidence interval, NRS: numeric rating scale, HADS: Hospital Anxiety and Depression Scale.
patients [3,4]. These two studies were conducted with small 
populations of less than 100 patients. The sample size, 
clinical setting and cultural differences may account for the 
discrepancy in the prevalence of clinical insomnia. However, 
the prevalence of insomnia (ISI ≥ 8) based on a subjective 
measure using the ISI in CLBP in this study was 43%. This 
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prevalence is higher by approximately fivefold compared to 
a large cohort study in a general Asian population without 
CLBP which included Koreans [12]. 
In the present study, comorbid musculoskeletal pain 
other than low back pain was revealed to be, among vari-
ous factors, the strongest risk factor for insomnia in CLBP 
patients. Although all patients reported low back pain as 
a chief complaint in this study, nearly 20% of patients 
complained of comorbid musculoskeletal pain at sites such 
as the neck, shoulders, arms, and joints, which may re-
quire medical attention. Instances of chronic muscu-
loskeletal pain in the neck [13], shoulder [14], or knee joint 
[15] were closely linked to insomnia in previous studies. 
Patients with musculoskeletal chronic pain have an in-
creased risk of poor mental health and a diminished quality 
of life [16]. One interesting study recently showed that the 
number of pain sites was a strong independent predictor 
of an individual’s lower ability to work, indicating an im-
pairment of social functioning [17]. Also, patients who 
present in primary care with multiple areas of regional pain 
have characteristics similar to those associated with 
chronic widespread pain and fibromyalgia [18]. Chronic pain 
sufferers generally appear to focus on the area that is 
most intense or that causes the greatest functional limita-
tion. Other bodily pains seem small in contrast and are de-
emphasized when the patient initially describes the nature 
and locations of their complaints. However, an initial single 
site of chronic pain may cause central sensitization, there-
by increasing the risk of experiencing pain in other body 
regions. Collectively, our study suggests that CLBP pa-
tients with comorbid multiple pain sites are highly suscep-
tible to developing insomnia.
Similar to our study, most previous studies consistently 
reported that high pain intensity is significantly associated 
with insomnia in CLBP patients [3-5]. Marin et al. reported 
that there was a significant relationship between pain and 
sleep, with a 55% increase in the proportion of patients 
reporting restless or light sleep after the onset of pain [5]. 
Also, a bidirectional relationship between pain and sleep 
was reportedly associated with CLBP [19]. A disrupted sleep 
cycle can exacerbate pain, creating a vicious cycle in which 
insomnia caused by pain further aggravates the pain.
In this study, 30% of CLBP patients reported symp-
toms suggesting neuropathic pain other than the lower 
back. This result is similar to that of a large cohort study 
[1]. On the other hand, we found no significant relationship 
between leg pain (sciatica) which may be caused by nerve 
root compression or irritation and insomnia. This indicates 
that the central mechanism of neuropathic pain may pre-
dominantly affect insomnia rather than a peripheral mech-
anism acting on an affected spinal nerve, although causes 
of neuropathic pain other than lower back could not be 
clearly determined in this study. Recent animal studies also 
demonstrated that neuropathic pain-like stimuli suppress 
the GABAergic transmission with increased GABA (γ-ami-
nobutyric acid) transporters located on activated as-
trocytes in the cingulate cortex related to insomnia [20,21]. 
Centrally mediated symptoms such as anxiety, de-
pression and sleep disturbance are frequently observed in 
chronic pain conditions [19]. In a univariate analysis, both 
a high level of anxiety and a high level of depression (HADS 
8 ≥ in both cases) were significantly associated with clin-
ical insomnia in CLBP, although only depression remained 
an independent factor associated with clinical insomnia af-
ter adjusting for other factors in this study. Approximately 
40% of adults with insomnia have a diagnosable psychiatric 
disorder, in most cases depression and/or anxiety, which 
may be a consequence of sleep deprivation as well as a 
risk factor for its development [22]. Also, Artner et al. re-
ported a 54% prevalence of a psychological disorder in 
CLBP patients despite their receiving multimodal pain 
management [23]. Moreover, Chiu et al. demonstrated that 
depression and sleep disturbance are independently asso-
ciated with a reduced pain threshold [24]. Thus, CLBP pa-
tients with depression are highly susceptible to insomnia, 
and insomnia may be considered an independent symptom 
when devising treatment strategies for this subgroup, 
which is more prone to poor clinical outcomes.
Another key aspect of this study is the set of patient 
demographic factors, may not relatively affect insomnia in 
CLBP compared to other clinical characteristics. In the 
general population, age and gender are the most clearly 
identified demographic risk factors for insomnia, with an 
increased prevalence in women and older adults [6]. However, 
these demographic factors appear to be modest during in-
somnia in CLBP patients. In several studies dealing with 
insomnia in CLBP and in our study, no relationship be-
tween insomnia and age, gender, or BMI has been reported 
[3-5].
This study has several limitations. First, the study was 
conducted in a single clinical setting including a selected 
study population with a homogeneous racial background. 
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Secondly, our findings are cross-sectional in nature; thus, 
a causal relationship between insomnia and current pain 
or sleep treatments cannot be determined definitely. Also, 
the ISI does not contain parameters for measuring the fre-
quency and duration of insomnia, or medication use, which 
may play unknown roles in determining the severity of 
insomnia. Finally, this study was based on a subjective as-
sessment of insomnia. Although the ISI has obvious ad-
vantages over other available measurements of insomnia 
in busy clinical settings, it appears to be important to in-
corporate an objective assessment of sleep with poly-
somnographic or actigraphic evidence [25]. 
In conclusion, we have demonstrated that CLBP pa-
tients who have high pain intensity, comorbid muscu-
loskeletal pain and neuropathic pain components, and high 
level of depression are strongly linked to clinical insomnia. 
Insomnia should be addressed as an integral part of pain 
management in CLBP patients with these risk factors, es-
pecially in patients suffering from CLBP with comorbid 
musculoskeletal pain. 
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